Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Operating Expenses: 2010-2025

Historic Operating Expenses for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to $4.6 million.

  • ProPhase Labs' Operating Expenses fell 30.68% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year increase of 7.14%. This contributed to the annual value of $38.5 million for FY2024, which is 4.63% up from last year.
  • Latest data reveals that ProPhase Labs reported Operating Expenses of $4.6 million as of Q3 2025, which was up 0.28% from $4.6 million recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Operating Expenses peaked at $17.1 million during Q4 2024, and registered a low of $4.2 million during Q1 2025.
  • Its 3-year average for Operating Expenses is $8.1 million, with a median of $7.2 million in 2023.
  • As far as peak fluctuations go, ProPhase Labs' Operating Expenses skyrocketed by 528.04% in 2021, and later tumbled by 55.90% in 2023.
  • Quarterly analysis of 5 years shows ProPhase Labs' Operating Expenses stood at $10.9 million in 2021, then spiked by 49.65% to $16.4 million in 2022, then tumbled by 55.90% to $7.2 million in 2023, then skyrocketed by 137.40% to $17.1 million in 2024, then slumped by 30.68% to $4.6 million in 2025.
  • Its last three reported values are $4.6 million in Q3 2025, $4.6 million for Q2 2025, and $4.2 million during Q1 2025.